The Limited Times

Now you can see non-English news...

Covid-19: Moderna chooses Recipharm to produce its vaccine in France

2020-11-26T07:40:23.857Z


The vaccine will be produced in Indre-et-Loire. The laboratory began to recruit more staff and made investments.


The pharmaceutical subcontracting laboratory Recipharm was chosen by the American biotech Moderna to produce part of its candidate vaccine against Covid-19 in France, he announced in a press release on Tuesday evening.

Recipharm has signed a letter of intent with Moderna to produce its vaccine in France at its site in Monts, in Indre-et-Loire, an agreement which must be finalized in December, indicates the Swedish laboratory, present in France since 2007.

The group has started to recruit more staff and made investments to enable technology transfer to be imminent, he said.

An agreement hailed by Bercy

In another press release, the Ministry of the Economy welcomed this letter of intent on Wednesday, and indicated that the French state is currently discussing with Recipharm to support its development and increase its capacity to provide vaccine doses.

The Recipharm group is present in France on four sites: Fontaine-les-Dijon (Côte-d'Or), Kaysersberg (Haut-Rhin), Pessac (Gironde) and Monts, specializing in injectable drugs and sterile forms for human use, veterinary or for clinical trials

The American biotech Moderna recently announced that its vaccine, based on innovative messenger RNA technology, was 94.5% effective, and plans to manufacture 20 million doses by the end of the year.

READ ALSO>

Covid-19: what we know about Moderna's vaccine, announced to be 94.5% effective


Moderna had already signed an agreement in the spring with the Swiss group Lonza, a giant in pharmaceutical subcontracting, to be able to manufacture up to one billion doses per year.

Lonza is in charge of the molecule synthesis, while Recipharm will be in charge of the formulation and bottling part.

Newsletter - Most of the news

Every morning, the news seen by Le Parisien

I'm registering

Your email address is collected by Le Parisien to enable you to receive our news and commercial offers.

Learn more

A few days ago, the French Delpharm indicated that it was going to produce part of Pfizer and BioNTech's vaccines against Covid-19, in its plant in Saint-Rémy-en-Avre.

Source: leparis

All life articles on 2020-11-26

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.